ClinicalTrials.Veeva

Menu

Salivary Immunoglobulin A (sIgA) Normal Range Study

4

4Life Research

Status

Completed

Conditions

Salivary Immunity

Treatments

Device: PoC Device

Study type

Observational

Funder types

Industry

Identifiers

NCT06248788
RSC-014-00

Details and patient eligibility

About

Salivary Immunoglobulin A (sIgA) is a marker of immune system activity. Typically, sIgA is determined by an ELISA test in which samples have to be sent to a specialized laboratory for testing. Investigators have developed a new instrument that is small, portable, and easy to use. This instrument is available for consumers to purchase and test their own sIgA at home.

Enrollment

47 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults committed to attend the session and follow the instructions described in Experimental Design will be included.

Exclusion criteria

  • Participant with mouth infection or oral disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems